The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The In Vitro Diagnostics Market In 2026 And What Value Is Projected For 2030?
The in vitro diagnostics market has experienced rapid growth in its size over recent years. It is anticipated to expand from $136.55 billion in 2025 to $152.42 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The historical growth can be attributed to factors such as an expansion in diagnostic testing volumes, an increase in infectious disease screening, the rising prevalence of chronic diseases, advancements in laboratory infrastructure, and broader healthcare access.
The in vitro diagnostics market is projected for swift expansion over the coming years. This market is anticipated to reach $241.14 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. Factors contributing to this growth during the forecast period include the increasing embrace of decentralized diagnostics, greater investments in molecular testing technologies, the broadening of personalized medicine diagnostics, an escalating need for quick and precise testing, and the rising incorporation of AI-driven diagnostics. Key trends anticipated for the forecast period encompass a wider acceptance of point-of-care diagnostic devices, an escalating requirement for molecular and immunoassay testing, the increasing deployment of automated laboratory systems, the proliferation of multiplex diagnostic platforms, and a heightened emphasis on swift testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp
What Key Drivers Are Influencing The Growth Of The In Vitro Diagnostics Market?
The rising incidence of cancer is anticipated to drive the expansion of the in vitro diagnostics market. Cancer itself is a diverse group of over 100 diseases that can manifest in various parts of the body. This increasing prevalence of cancer is attributable to shifts in lifestyle, including heightened tobacco consumption, inadequate dietary practices, a lack of physical activity, and environmental pollution, which collectively elevate cancer risk across populations. In vitro diagnostics (IVDs) encompass a category of tests or medical devices that analyze samples taken from the human body, delivering critical information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported that the United States was projected to have 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Thus, the escalating prevalence of cancer is expected to fuel the growth of the in vitro diagnostics market.
What Are The Key Segments Of The In Vitro Diagnostics Market?
The in vitro diagnostics market covered in this report is segmented –
1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By Type of Expenditure: Public, Private
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing
2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)
3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing
4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices
5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems
6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers
7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters
8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers
What Key Trends Are Influencing The Development Of The In Vitro Diagnostics Market?
Major companies operating in the in vitro diagnostics market are integrating advanced technologies, such as UIMG image technology and a 2D decoder chip, to elevate the precision and effectiveness of diagnostic tests, refine data analysis, optimize workflow processes, and ultimately achieve better patient outcomes. UIMG image technology specifically functions as an advanced imaging method in diagnostics, designed to capture and analyze high-resolution images, thereby enhancing the visualization and interpretation of biological samples. For example, in November 2023, Newland, an EMEA, Netherlands-based technology company, introduced its IVD (in vitro diagnostics) product line. This new IVD product range consists of five barcode scanners that are compact, robust, and specifically designed for automated diagnostic processes. These scanners aim to improve the speed and accuracy of diagnostics, which is particularly vital given the increasing need for efficient healthcare solutions.
Who Are The Leading Companies Operating In The In Vitro Diagnostics Market?
Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.
Read the full in vitro diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Which Region Is Expected To Register The Fastest Growth In The In Vitro Diagnostics Market?
North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored In Vitro Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Market Report 2026
In Vitro Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
In Vitro Diagnostics Enzymes Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model